We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MorphoSys Announces Clinical Milestone for Start of Bayer's Phase 2 Trial

News   Jan 27, 2016

 
MorphoSys Announces Clinical Milestone for Start of Bayer's Phase 2 Trial
 
 
 

RELATED ARTICLES

Zika Study May "Supercharge" Vaccine Research

News

Scientists looking at the genetics of Zika virus have found a way to fast-track research which could lead to new vaccines.

READ MORE

FDA Approves First Treatment for Postpartum Depression

News

The U.S. Food and Drug Administration today approved Zulresso (brexanolone) injection for intravenous (IV) use for the treatment of postpartum depression (PPD) in adult women. This is the first drug approved by the FDA specifically for PPD.

READ MORE

Meningitis Changes Immune Cell Makeup in the Mouse Brain Lining

News

NIH study finds new cell composition may lead to less effective future response.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE